Enzymatic chokepoints and synergistic drug targets in the sterol biosynthesis pathway of Naegleria fowleri
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enzymatic chokepoints and synergistic drug targets in the sterol biosynthesis pathway of Naegleria fowleri
Authors
Keywords
Sterols, Naegleria fowleri, Biosynthesis, Cholesterol, Trophozoites, Primary amoebic meningoencephalitis, Enzyme metabolism, Drug delivery
Journal
PLoS Pathogens
Volume 14, Issue 9, Pages e1007245
Publisher
Public Library of Science (PLoS)
Online
2018-09-14
DOI
10.1371/journal.ppat.1007245
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)
- (2017) Anjan Debnath et al. PLoS Neglected Tropical Diseases
- Sterol targeting drugs reveal life cycle stage-specific differences in trypanosome lipid rafts
- (2017) Aabha I. Sharma et al. Scientific Reports
- Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51)
- (2015) David C. Lamb et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Naegleria fowleri: Pathogenesis, Diagnosis, and Treatment Options
- (2015) Eddie Grace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- PotentIn VitroAntiproliferative Synergism of Combinations of Ergosterol Biosynthesis Inhibitors against Leishmania amazonensis
- (2015) S. T. de Macedo-Silva et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Use of the Novel Therapeutic Agent Miltefosine for the Treatment of Primary Amebic Meningoencephalitis: Report of 1 Fatal and 1 Surviving Case: Table 1.
- (2015) Jennifer R. Cope et al. CLINICAL INFECTIOUS DISEASES
- Genome-wide identification of pathogenicity factors of the free-living amoeba Naegleria fowleri
- (2014) Denise C Zysset-Burri et al. BMC GENOMICS
- Novel cathepsin B and cathepsin B-like cysteine protease of Naegleria fowleri excretory–secretory proteins and their biochemical properties
- (2014) Jinyoung Lee et al. PARASITOLOGY RESEARCH
- Corifungin, a New Drug Lead against Naegleria, Identified from a High-Throughput Screen
- (2012) Anjan Debnath et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- IsoCor: correcting MS data in isotope labeling experiments
- (2012) P. Millard et al. BIOINFORMATICS
- Sigma-1 Receptor Agonists as Therapeutic Drugs for Cognitive Impairment in Neuropsychiatric Diseases
- (2012) Tomihisa Niitsu et al. CURRENT PHARMACEUTICAL DESIGN
- A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target
- (2012) Anjan Debnath et al. NATURE MEDICINE
- Sink or swim: lipid rafts in parasite pathogenesis
- (2012) Amanda M. Goldston et al. TRENDS IN PARASITOLOGY
- The Rieske oxygenase DAF-36 functions as a cholesterol 7-desaturase in steroidogenic pathways governing longevity
- (2011) Joshua Wollam et al. AGING CELL
- Novel sterol metabolic network ofTrypanosoma bruceiprocyclic and bloodstream forms
- (2011) Craigen R. Nes et al. BIOCHEMICAL JOURNAL
- Biosynthesis of Cholesterol and Other Sterols
- (2011) W. David Nes CHEMICAL REVIEWS
- Origin and evolution of the worldwide distributed pathogenic amoeboflagellate Naegleria fowleri
- (2011) Johan F. De Jonckheere INFECTION GENETICS AND EVOLUTION
- Lipid Rafts As a Membrane-Organizing Principle
- (2010) D. Lingwood et al. SCIENCE
- Phylogenomics of Sterol Synthesis: Insights into the Origin, Evolution, and Diversity of a Key Eukaryotic Feature
- (2009) Elie Desmond et al. Genome Biology and Evolution
- The pharmacology of sigma-1 receptors
- (2009) Tangui Maurice et al. PHARMACOLOGY & THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now